CIK 0001356090
- Non-accelerated filer
- Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- 4 Exercise or conversion Chief Commercial Officer acquired 62,500 shares (option exercise)
- 4 Exercise or conversion Chief Operating Officer acquired 90,000 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 250,000 shares (option exercise)
- 4 Exercise or conversion Chief Legal Officer acquired 62,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 4,772,781 shares at $3.30 ($15,750,177)
- 4 Exercise or conversion Chief Financial Officer acquired 40,293 shares (option exercise)
- 4 Exercise or conversion Chief Commercial Officer acquired 42,110 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 321,100 shares (option exercise)
- 4 Exercise or conversion Chief Operating Officer acquired 44,495 shares (option exercise)
- 4 Exercise or conversion Chief Legal Officer acquired 40,443 shares (option exercise)
- 4 Exercise or conversion Director acquired 143,678 shares (option exercise)
- 4 Exercise or conversion Director acquired 71,839 shares (option exercise)
- 4 Exercise or conversion Director acquired 71,839 shares (option exercise)
- 4 Exercise or conversion Director acquired 71,839 shares (option exercise)
- 4 Exercise or conversion Director acquired 71,839 shares (option exercise)
Page 2 of 41 · 817 filings